Trial
NCT01473732
Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Montefiore Medical Center
Collaborators
—
Condition
Chronic Allograft Injury
Intervention
Everolimus
Why stopped
terminated after 2 patients due to difficulty in enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-10-16